Board of Directors was formed to provide guidance and deliberate on important company agendas, items stipulated by law or in the Article of Incoporation, details entrusted by general meetings of shareholders, the basic policies of business operations on essential pratices related to business management. The Board of Medy-tox also complies with Korean Commecial Law by organazing the number of non-executive directors who supervise the performance of directors' obligation to be at least a quarter of the total number of directors.
Board of Directors connsists of 3 Executive Directors, 2 Non-Executive Directors, and 1 Auditor, and the chairman of the board is appointed by resolution of the Board of Directors. Board of Directors is the company's highest decision-making body and determines key matters of the Company.
The Directors who make up Medy-Tox's board are appointed at the general shareholders' meeting. A candidate for director shall not be discriminated against by gender, race, origin, etc. We are trying to select candidates to meet their expertise and diversity. If there is a shareholder proposal in accordance with relevant laws and regulations regarding the appointment of a director, the board of directors may submit it as a bill to the general shareholders' meeting within a legitimate scope.